Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04655391
Title	Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell Transplantation
Recruitment	Withdrawn
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	City of Hope Medical Center
Indications	acute myeloid leukemia
Therapies	Glasdegib Glasdegib + Ivosidenib Bosutinib + Glasdegib Gilteritinib + Glasdegib Decitabine + Glasdegib + Venetoclax Enasidenib + Glasdegib
Age Groups:	adult \| senior
Covered Countries	USA